Novartis had more than 4,000 agency vendors. In-house production capabilities had been set up but were under-utilized with less than 1% of the work going to Production Hubs. The company wanted an independent assessment of their current model versus future needs, and recommendations beyond the agency model to ensure governance.
R3 delivered an optimized agency model that worked for both global and local markets. A strict governance approach was introduced to drive true leadership and transparency in Novartis’ future engagements.
Assessment – R3 reviewed more than 200 documents from previously conducted analysis, including agency scopes and performance evaluations, as well historical strategic and creative work.
Stakeholder & Expert Interviews – More than fifty interviews were conducted across 3 Business Units to understand the needs of the various stakeholders – Global Marketing, Local Market leads, as well as Agencies across 8 counties and 3 agency networks. Interviews with up to 10 leading global CMO’s/marketers.
Research – Review of external insights through research across the category and North Star brands to provide an independent point of view of best-in-class agency models.